PAHC
Phibro Animal Health Corporation
38.30$
+2.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 60.6% | 60.3% | 61.0% | 61.2% | 59.1% | 58.0% | 58.9% | 59.6% | 60.3% | 61.3% | 61.9% | 62.3% | |
| 4.5% | 3.4% | 5.1% | 7.2% | 5.4% | 5.2% | 4.6% | 5.0% | 5.3% | 3.9% | 3.8% | 4.1% | |
| 9.5% | 9.5% | 10.1% | 11.7% | 9.3% | 5.2% | 5.3% | 5.7% | 6.2% | 5.3% | 5.4% | 5.5% | |
| 15.5% | 15.5% | 16.5% | 17.3% | 16.6% | 14.9% | 15.0% | 16.8% | 15.7% | 15.4% | 15.3% | 15.9% | |
| 28.9% | 29.5% | 28.8% | 27.1% | 28.2% | 33.2% | 34.0% | 32.7% | 34.1% | 36.8% | 37.3% | 35.6% | |
| 5.5% | 5.6% | 5.6% | 5.6% | 5.6% | 4.2% | 4.1% | 4.4% | 4.3% | 4.3% | 4.1% | 4.0% | |
| 5.4% | 5.2% | 4.9% | 4.6% | 4.4% | 3.1% | 2.9% | 2.7% | 2.5% | 2.4% | 2.2% | 2.0% | |
| 71.7% | 72.2% | 72.4% | 73.9% | 73.2% | 80.8% | 79.8% | 79.0% | 77.5% | 76.4% | 75.0% | 74.3% | |
| 17.9% | 19.3% | 19.3% | 20.8% | 18.3% | 18.1% | 20.2% | 21.6% | 19.5% | 20.1% | 19.5% | 21.1% | |
| 3.2% | 3.4% | 3.8% | 3.8% | 1.6% | 1.9% | 1.9% | 1.9% | 2.0% | 2.1% | 2.2% | 2.4% | |
| 8.0% | 8.9% | 8.4% | 8.7% | 9.0% | 7.7% | 10.0% | 10.2% | 9.4% | 9.5% | 9.0% | 8.5% | |
| 47.6% | 46.1% | 46.6% | 46.7% | 48.3% | 57.3% | 54.0% | 51.6% | 52.3% | 50.6% | 49.3% | 47.1% | |
| 28.3% | 27.8% | 27.6% | 26.1% | 26.8% | 19.2% | 20.2% | 21.0% | 22.5% | 23.6% | 25.0% | 25.7% | |
| 25.7% | 25.1% | 25.3% | 24.8% | 25.5% | 19.0% | 19.8% | 20.0% | 21.2% | 22.6% | 23.3% | 23.5% | |
| 4.2% | 4.2% | 4.1% | 4.1% | 4.2% | 3.2% | 3.1% | 3.0% | 3.0% | 2.9% | 2.8% | 2.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.